What it is: Oral Liposomal BPC + TB-500 is a dual-peptide, fast-absorbing regenerative formula developed by Quicksilver Scientific, delivering 1,000 mcg of BPC (as Pentadeca Short Chain Amino Acids) and 1,000 mcg of TB-500 per 1 mL serving in the proprietary Quicksilver Delivery Systems® (QDS®) liposomal format. BPC is a 15-amino-acid bioactive sequence naturally derived from the Body Protection Compound protein found in the human digestive tract, and TB-500 is the active region of the endogenous healing protein Thymosin Beta-4 (Tβ4) — two of the most well-researched regenerative compounds currently available in the practitioner supplement channel. Delivered via QDS® nanoscale phospholipid vesicles of 20–100 nanometers that begin absorbing directly through oral mucosal membranes on contact, this formula provides enhanced bioavailability and cellular uptake for rapid, systemic delivery without invasive administration. Tested allergen-free, gluten-free, soy protein-free, non-GMO, vegan, and sugar-free, manufactured in an NSF GMP-certified facility. Shipped with ice packs and requiring refrigeration upon receipt, Oral Liposomal BPC + TB-500 is designed for exclusive practitioner-directed use in advanced tissue repair, recovery, musculoskeletal, vascular, neurological, and connective tissue support protocols.
How it works: Oral Liposomal BPC + TB-500 supports comprehensive tissue healing, muscle repair and growth, vascular and endothelial function, neurological resilience, and connective tissue integrity through the complementary and synergistic regenerative mechanisms of its two constituent peptides — each operating through distinct yet overlapping biological pathways that together provide broader tissue repair coverage than either compound achieves independently. BPC (1,000 mcg) exerts its regenerative activity through VEGF-mediated angiogenesis promoting new capillary formation in damaged tissue, growth hormone receptor upregulation in fibroblasts amplifying local connective tissue collagen synthesis and repair, nitric oxide pathway activation supporting vascular integrity and tissue perfusion, intestinal epithelial barrier stabilization for gut health and gut-brain axis support, and antioxidant and inflammatory-modulating activity. TB-500 (1,000 mcg) — the active actin-binding region of Thymosin Beta-4 — exerts its regenerative activity through G-actin sequestration and regulation that drives cellular migration and proliferation of endothelial cells, keratinocytes, and muscle satellite cells into sites of tissue damage, independent VEGF upregulation supporting neovascularization of healing tissue, suppression of pro-inflammatory cytokines to support a regulated healing environment, and activation of muscle satellite cells for skeletal muscle fiber repair and growth. Together, BPC's site-specific angiogenic and cytoprotective repair activity and TB-500's broader systemic cellular migration and immune-modulatory regenerative signaling provide a synergistic dual-peptide tissue repair system operating across both local repair and systemic regenerative signaling dimensions simultaneously — supporting comprehensive tissue healing including wounds and scars, muscle repair and growth, cardiovascular and endothelial health, neuroprotection, cognitive support, and skin and connective tissue resilience in aging.
When to use it: Oral Liposomal BPC + TB-500 is appropriate for exclusive practitioner-directed use in adult clients requiring advanced and accelerated tissue healing and recovery support — those recovering from acute injury, surgery, or significant physical overexertion where conventional recovery timelines are insufficient for clinical needs. It is specifically distinguished from the standalone BPC formula by its emphasis on broader musculoskeletal, vascular, and systemic cellular repair through the addition of TB-500 — making it the preferred combination for athletes, post-operative recovery protocols, and clients with significant musculoskeletal, vascular, or neurological tissue repair requirements. Two pumps (1 mL) held in the mouth for 30–90 seconds before swallowing on an empty stomach or at least 10 minutes before meals provides the full dual-peptide 2,000 mcg combined serving. This product requires refrigeration upon receipt and is stable for up to 7 days outside of refrigeration.
Serving Size: 1 mL (2 Pumps)
Servings Per Container: 30
Suggested Use: Take 2 pumps by mouth. Hold in mouth for 30–90 seconds before swallowing. Repeat to desired dosage or as directed by a healthcare practitioner. Best taken on an empty stomach or at least 10 minutes before meals.
|
Ingredient |
Amount Per Serving |
% Daily Value |
|
BPC (as Pentadeca Short Chain Amino Acids) |
1,000 mcg |
** |
|
TB-500 |
1,000 mcg |
** |
** Daily Value not established.
Other Ingredients: Water, glycerin, ethanol, highly purified phospholipids, tocofersolan, natural mixed tocopherols.
Caution: If pregnant or breastfeeding, consult your healthcare practitioner before use. Keep out of reach of children. Refrigerate upon receipt. Product is stable for up to 7 days outside of refrigeration. Do not use if tamper-evident seal is broken or missing.
✓ Vegan ✓ Gluten Free ✓ Soy Protein Free ✓ Non-GMO ✓ Sugar Free ✓ Allergen Tested ✓ NSF GMP Certified Facility
Key Ingredients
BPC (as Pentadeca Short Chain Amino Acids) — 1,000 mcg BPC is a 15-amino-acid bioactive sequence naturally derived from the Body Protection Compound protein found in the human digestive tract, delivered here as Pentadeca Short Chain Amino Acids in Quicksilver Scientific's QDS® liposomal format — nanoscale phospholipid vesicles that begin absorbing through oral mucosal membranes on contact, enabling rapid systemic delivery before exposure to digestive enzymatic degradation. BPC's regenerative activity operates through VEGF-mediated angiogenesis supporting new capillary formation in healing tissue, growth hormone receptor upregulation in fibroblasts amplifying connective tissue collagen synthesis and repair, nitric oxide pathway activation supporting vascular integrity, intestinal epithelial barrier stabilization for gut-brain axis support, and antioxidant and inflammatory-modulating activity that collectively address tissue repair across gut, tendon, ligament, muscle, vascular, and neurological compartments. At 1,000 mcg per serving, BPC provides the primary site-specific angiogenic, cytoprotective, and receptor-sensitizing repair mechanism within this dual-peptide formula, working in synergy with TB-500's systemic cellular migration and immune-modulatory regenerative activity to deliver broader tissue repair coverage than either compound achieves independently.
TB-500 — 1,000 mcg TB-500 is the active actin-binding region of Thymosin Beta-4 (Tβ4) — a 43-amino-acid endogenous healing protein present in virtually all human tissues — delivering the primary bioactive sequence responsible for Tβ4's regenerative activity in a liposomal-optimized format that enables oral delivery through Quicksilver's QDS® nanoscale phospholipid vesicles. TB-500's primary mechanism involves G-actin sequestration and regulation driving the cytoskeletal reorganization that promotes cellular migration and proliferation of endothelial cells, keratinocytes, and muscle satellite cells into sites of tissue damage — providing the cellular trafficking infrastructure necessary for organized tissue repair across wound healing, muscle regeneration, and connective tissue recovery. TB-500 independently stimulates VEGF and pro-angiogenic growth factor upregulation to support neovascularization, suppresses pro-inflammatory cytokines to support a regulated immune healing environment, and activates muscle satellite cells for skeletal muscle fiber repair and growth — providing the systemic cellular migration and broad angiogenic regenerative activity that complements BPC's localized repair mechanisms, together creating a comprehensive dual-peptide tissue healing system addressing both cellular trafficking and local growth factor signaling dimensions of musculoskeletal, vascular, and connective tissue repair.
